TW200640948A - DR5 antibodies and uses thereof - Google Patents

DR5 antibodies and uses thereof

Info

Publication number
TW200640948A
TW200640948A TW095103829A TW95103829A TW200640948A TW 200640948 A TW200640948 A TW 200640948A TW 095103829 A TW095103829 A TW 095103829A TW 95103829 A TW95103829 A TW 95103829A TW 200640948 A TW200640948 A TW 200640948A
Authority
TW
Taiwan
Prior art keywords
antibodies
cancer
compositions
treatment
making
Prior art date
Application number
TW095103829A
Other languages
Chinese (zh)
Other versions
TWI419903B (en
Inventor
Camellia Adams
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of TW200640948A publication Critical patent/TW200640948A/en
Application granted granted Critical
Publication of TWI419903B publication Critical patent/TWI419903B/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention concerns anti-DR5 antibodies with improved properties, compositions comprising such antibodies, methods and means for making such antibodies, and their therapeutic use, in particular in the treatment of cancer.
TW95103829A 2005-02-02 2006-02-03 Dr5 antibodies and uses thereof TWI419903B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64955005P 2005-02-02 2005-02-02

Publications (2)

Publication Number Publication Date
TW200640948A true TW200640948A (en) 2006-12-01
TWI419903B TWI419903B (en) 2013-12-21

Family

ID=37820467

Family Applications (1)

Application Number Title Priority Date Filing Date
TW95103829A TWI419903B (en) 2005-02-02 2006-02-03 Dr5 antibodies and uses thereof

Country Status (4)

Country Link
AR (1) AR052109A1 (en)
MY (1) MY160566A (en)
TW (1) TWI419903B (en)
ZA (1) ZA200706246B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2287911C (en) * 1997-05-15 2014-05-06 Genentech, Inc. Apo-2 receptor

Also Published As

Publication number Publication date
ZA200706246B (en) 2008-11-26
TWI419903B (en) 2013-12-21
MY160566A (en) 2017-03-15
AR052109A1 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
HK1109638A1 (en) Dr5 antibodies and uses thereof dr5
IL258880A (en) Diarylhydantoin compounds
IL244803A0 (en) Humanized anti-beta7 antibodies and uses therefore
WO2007053573A3 (en) Treatment of cancer with sorafenib
WO2007061874A3 (en) Methods and compositions for use in treating cancer
MX2007011545A (en) Combinations for the treatment of cancer comprising anti-egfr antibody and vegfr inhibitors.
MX2009006466A (en) Methods of treatment.
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
SG164368A1 (en) Treatment of cancer
WO2006113483A3 (en) Methods and compositions for treating or preventing cancer
MX2009008430A (en) Anti-robo4 antibodies and uses therefor.
IL214325A (en) Anti-cmet antibody, composition comprising it and use thereof
MXPA06014510A (en) Compositions and methods for treating inflammatory disorders.
WO2007064872A3 (en) Urea compounds useful in the treatment of cancer
WO2008124660A3 (en) Methods and compositions for the treatment of cancer
SG160412A1 (en) Anti-igfr1 antibody therapeutic combinations
NZ599875A (en) Human il-23 antigen binding proteins
MX2009008347A (en) Oxabicycloheptanes and oxabicycloheptenes, their preparation and use.
JO2795B1 (en) Immunoglobulines
NZ579478A (en) Epha3 antibodies for the treatment of solid tumors
TW200716088A (en) Formulations and methods for treating amyloidosis
UA99601C2 (en) Use of an anti-cd151 antibody in the treatment of cancer
MX2009010269A (en) Methods of treating cancer by administering human il-18 combinations.
DE602005015329D1 (en) RUTHENIUM COMPOSITIONS FOR CANCER TREATMENT
TW200640948A (en) DR5 antibodies and uses thereof